|
Ethic committee approvals |
|
| Study |
Ethical Committee |
|
|
|
| - single-dose, comparing 1 and 2 mg lozenges with 2 mg gum - multiple-dose, comparing 1 mg lozenge with 2 mg gum |
CCPPRB de Franche-Comté, France |
| - multiple-dose, comparing 1 and 2 mg lozenges with 4 mg gum |
CCPPRB of the Hôtel-Dieu Hospital (Lyon – France) |
| - safety assessment of 1 mg lozenge after swallowing |
CREC Regipharm (Brussels – Belgium) |
| - French efficacy trial |
CCPPRB of the Pitié-Salpêtrière Hospital (Paris – France) |
| - US efficacy trial |
IRB at Research Testing Laboratories, Inc. (Great Neck, NY, USA) |
Dautzenberg et al. BMC Clinical Pharmacology 2007 7:11 doi:10.1186/1472-6904-7-11 |
|